Survival outcomes of low-risk and intermediate-risk stage IB1 cervical cancer patients

[1]Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997; 350:535–40.LandoniFManeoAColomboAPlacaFMilaniRPeregoPet alRandomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerLancet19973505354010.1016/S0140-6736(97)02250-2Search in Google Scholar

[2]Delgado G, Bundy BN, Fowler WC Jr., Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989; 35:314–20.DelgadoGBundyBNFowlerWC Jr.StehmanFBSevinBCreasmanWTet alA prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group StudyGynecol Oncol1989353142010.1016/0090-8258(89)90070-XSearch in Google Scholar

[3]Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001; 80:3–12.LandoniFManeoACormioGPeregoPMilaniRCarusoOet alClass II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized studyGynecol Oncol20018031210.1006/gyno.2000.6010Search in Google Scholar

[4]Kinney WK, Alvarez RD, Reid GC, Schray MF, Soong SJ, Morley GW, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol. 1989; 34:258–62.KinneyWKAlvarezRDReidGCSchrayMFSoongSJMorleyGWet alValue of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control studyGynecol Oncol1989342586210.1016/0090-8258(89)90156-XSearch in Google Scholar

[5]Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000; 18:1606–13.PetersWA3rdLiuPYBarrettRJ2ndStockRJMonkBJBerekJSet alConcurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixJ Clin Oncol20001816061310.1200/JCO.2000.18.8.1606Search in Google Scholar

[6]Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999; 73:177–83.SedlisABundyBNRotmanMZLentzSSMuderspachLIZainoRJA randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group StudyGynecol Oncol1999731778310.1097/00006254-199909000-00017Search in Google Scholar

[7]Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990; 38:352–7.DelgadoGBundyBZainoRSevinBUCreasmanWTMajorFProspective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyGynecol Oncol199038352710.1016/0090-8258(90)90072-SSearch in Google Scholar

[8]Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002; 84:145–9.CovensARosenBMurphyJLaframboiseSDePetrilloADLickrishGet alHow important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol200284145910.1006/gyno.2001.649311748991Search in Google Scholar

[9]Stegeman M, Louwen M, van der Velden J, ten Kate FJ, den Bakker MA, Burger CW, et al. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol. 2007; 105:475–80.StegemanMLouwenMvan derVelden Jten KateFJden BakkerMABurgerCWet alThe incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomyGynecol Oncol20071054758010.1016/j.ygyno.2007.01.01617292460Search in Google Scholar

[10]Ayhan A, Al RA, Baykal C, Demirtas E, Yuce K, Ayhan A. A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer. 2004; 14:279–85.AyhanAAlRABaykalCDemirtasEYuceKAyhanAA comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinomaInt J Gynecol Cancer2004142798510.1136/ijgc-00009577-200403000-00014Search in Google Scholar

[11]Trimbos JB, Lambeek AF, Peters AA, Wolterbeek R, Gaarenstroom KN, Fleuren GJ, et al. Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer. Gynecol Oncol. 2004; 95:77–81.TrimbosJBLambeekAFPetersAAWolterbeekRGaarenstroomKNFleurenGJet alPrognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancerGynecol Oncol200495778110.1016/j.ygyno.2004.06.025Search in Google Scholar

[12]Singh P, Tripcony L, Nicklin J. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix. Int J Gynecol Cancer. 2012; 22:115–22.SinghPTripconyLNicklinJAnalysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervixInt J Gynecol Cancer2012221152210.1097/IGC.0b013e31822fa8bbSearch in Google Scholar

[13]Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 1987; 26:153–9.BurkeTWHoskinsWJHellerPBBibroMCWeiserEBParkRCPrognostic factors associated with radical hysterectomy failureGynecol Oncol198726153910.1016/0090-8258(87)90268-XSearch in Google Scholar

[14]Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000; 79:289–93.NakanishiTIshikawaHSuzukiYInoueTNakamuraSKuzuyaKA comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervixGynecol Oncol2000792899310.1006/gyno.2000.5935Search in Google Scholar

[15]Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995; 76 Suppl 10:1948–55.ShingletonHMBellMCFremgenAChmielJSRussellAHJonesWBet alIs there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer199576Suppl1019485510.1002/1097-0142(19951115)76:10+<1948::AID-CNCR2820761311>3.0.CO;2-TSearch in Google Scholar

[16]Ishikawa H, Nakanishi T, Inoue T, Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol. 1999; 73:42–6.IshikawaHNakanishiTInoueTKuzuyaKPrognostic factors of adenocarcinoma of the uterine cervixGynecol Oncol19997342610.1006/gyno.1998.5291Search in Google Scholar

[17]Matthews CM, Burke TW, Tornos C, Eifel PJ, Atkinson EN, Stringer CA, et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993; 49:19–23.MatthewsCMBurkeTWTornosCEifelPJAtkinsonENStringerCAet alStage I cervical adenocarcinoma: prognostic evaluation of surgically treated patientsGynecol Oncol199349192310.1006/gyno.1993.1079Search in Google Scholar

[18]Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer. 1995; 76 Suppl 10:1978–86.SevinBUNadjiMLampeBLuYHilsenbeckSKoechliORet alPrognostic factors of early stage cervical cancer treated by radical hysterectomyCancer199576Suppl1019788610.1002/1097-0142(19951115)76:10+<1978::AID-CNCR2820761313>3.0.CO;2-KSearch in Google Scholar

[19]Lee KB, Lee JM, Ki KD, Lee SK, Park CY, Ha SY. Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer. Int J Gynecol Cancer. 2008; 18:1027–31.LeeKBLeeJMKiKDLeeSKParkCYHaSYComparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancerInt J Gynecol Cancer20081810273110.1111/j.1525-1438.2007.01136.xSearch in Google Scholar

[20]Takeshima N, Umayahara K, Fujiwara K, Hirai Y, Takizawa K, Hasumi K. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer. Gynecol Oncol. 2006; 103:618–22.TakeshimaNUmayaharaKFujiwaraKHiraiYTakizawaKHasumiKTreatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancerGynecol Oncol20061036182210.1016/j.ygyno.2006.04.019Search in Google Scholar

[21]Boyce J, Fruchter RG, Nicastri AD, Ambiavagar PC, Reinis MS, Nelson JH Jr. Prognostic factors in stage I Carcinoma of the cervix. Gynecol Oncol. 1981; 12:154–65.BoyceJFruchterRGNicastriADAmbiavagarPCReinisMSNelsonJH JrPrognostic factors in stage I Carcinoma of the cervixGynecol Oncol1981121546510.1016/0090-8258(81)90145-1Search in Google Scholar

[22]Gemer O, Eitan R, Gdalevich M, Mamanov A, Piura B, Rabinovich A, et al. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement. Eur J Surg Oncol. 2013; 39:76–80.GemerOEitanRGdalevichMMamanovAPiuraBRabinovichAet alCan parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvementEur J Surg Oncol201339768010.1016/j.ejso.2012.10.01323131429Search in Google Scholar

[23]Manchana T, Sirisabya N, Lertkhachonsuk R, Worasethsin P, Khemapech N, Sittisomwong T, et al. Long term complications after radical hysterectomy with pelvic lymphadenectomy. J Med Assoc Thai. 2009; 92:451–6.ManchanaTSirisabyaNLertkhachonsukRWorasethsinPKhemapechNSittisomwongTet alLong term complications after radical hysterectomy with pelvic lymphadenectomyJ Med Assoc Thai2009924516Search in Google Scholar

[24]Ralph G, Winter R, Michelitsch L, Tamussino K. Radicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy. Eur J Gynaecol Oncol. 1991; 12:27–30.RalphGWinterRMichelitschLTamussinoKRadicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomyEur J Gynaecol Oncol1991122730Search in Google Scholar